Neurologic syndromes related to anti-GAD65

Autoantibodies against glutamic acid decarboxylase (GAD) 65 have been linked to different types of syndromes. These antibodies are widely used as biomarkers for diabetes mel-litus type 1 (DM1) diagnosis because they are present in 80% of patients at diagnosis.1,2 However, it is well known that anti-GAD65 can also be associated with specificneu- ................
................